B-Cell Non-Hodgkin Lymphoma — Trials

B-Cell Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

6,180 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,757
Recruiting: 905
Ph III recruiting: 103
Growth YoY: +6.8%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (953)

clinicaltrialsPublishedShowing 601–607 of 607 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00376883	Pamidronate Prophylaxis in Multiple Myeloma 30 mg/Month Versus 90 mg/Month	completed	Phase 3	500	Nordic Myeloma Study GroupOTHER	3	Jan 4, 2007	clinicaltrials
NCT00037791	Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia	completed	Phase 3	180	PfizerINDUSTRY	3	Nov 9, 2006	clinicaltrials
NCT00300664